Century Therapeutics Inc
IPSC
Get informed when a big investor buys or sells
+ FollowMarket Cap$175.3M
Close$
$-0.25
112% downside
Current Fair Value
112% downsideOvervalued by 112% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $175.30 Million |
|---|---|
| Enterprise Value | $160.29 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.11 |
| Beta | 1.6 |
| Outstanding Shares | 205,778,156 |
Return
| Return on Equity | -47.25% |
|---|---|
| Return on Assets | -38.25% |
| Return on Invested Capital | -44.11% |
Valuation & Multiples
| P/E Ratio | -1.95 |
|---|---|
| PEG | -31.54 |
| Price to Sales | - |
| Price to Book Ratio | 2.09 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.34 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$2.17 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$1.63 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 41,500▲ Infinity% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 160.30%▲ 130.60% |
|---|---|
| Total Invested | $312.46M▲ 1121.97% |
| Investors Holding | 74▲ 28.00% |
ESG Score
No data
About Century Therapeutics Inc
102 employees